trial · primary record
Fenofibrate
Primary Biliary Cholangitis
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 117 |
| Primary completion | 2027-04 |
| Primary endpoint | Treatment emergent adverse events (TEAEs) |
| Registry ID | NCT06365424 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:51.054Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06365424
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Fenofibrate · approval
- Fenofibrate · compound